GKIM
ABMD

GW&K Investment Management’s Abiomed Inc ABMD Stock Holding History

GW&K Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14
Closed -$3K – 844
2022
Q2 		$3K Buy
14
+5
+56% +$1.35K ﹤0.01% 719
2022
Q1 		$3K Buy
+9
New +$2.77K ﹤0.01% 675
2019
Q4 		– Sell
-25
Closed -$4K – 381
2019
Q3 		$4K Buy
+25
New +$5.4K ﹤0.01% 365
2017
Q4 		– Sell
-24,122
Closed -$4.07M – 276
2017
Q3 		$4.07M Sell
24,122
-288
-1% -$43.5K 0.07% 198
2017
Q2 		$3.5M Sell
24,410
-575
-2% -$77.3K 0.06% 192
2017
Q1 		$3.13M Sell
24,985
-595
-2% -$69K 0.06% 193
2016
Q4 		$2.88M Sell
25,580
-3,848
-13% -$446K 0.06% 197
2016
Q3 		$3.78M Sell
29,428
-1,823
-6% -$218K 0.07% 191
2016
Q2 		$3.42M Buy
31,251
+3,065
+11% +$305K 0.07% 190
2016
Q1 		$2.67M Buy
28,186
+2,492
+10% +$210K 0.06% 197
2015
Q4 		$2.32M Sell
25,694
-719
-3% -$61K 0.05% 182
2015
Q3 		$2.45M Sell
26,413
-12,568
-32% -$1.11M 0.06% 177
2015
Q2 		$2.56M Sell
38,981
-1,238
-3% -$82.3K 0.06% 179
2015
Q1 		$2.88M Buy
40,219
+889
+2% +$48.3K 0.07% 180
2014
Q4 		$1.5M Buy
+39,330
New +$1.24M 0.04% 190

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

GW&K Investment Management's ABMD Position: Q3 2022 in Review

GW&K Investment Management sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 14 shares — an estimated $3K sold.

GW&K Investment Management first reported a position in ABMD in Q4 2014 and held it in 15 quarters. The position peaked at $4.07M in Q3 2017. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

  • GW&K Investment Management reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
  • GW&K Investment Management sold 14 Abiomed Inc shares in Q3 2022, an estimated $3K.
  • GW&K Investment Management first reported a position in Abiomed Inc in Q4 2014 and held it in 15 quarters.
  • GW&K Investment Management's Abiomed Inc position peaked at $4.07M in Q3 2017.
  • 517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on GW&K Investment Management's 13F filing for Q3 2022, filed 9 Nov 2022.